Skip to main navigation Skip to search Skip to main content

A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancer

  • William J. Gradishar
  • , Virginia Kaklamani
  • , Tarini P. Sahoo
  • , Dasappa Lokanatha
  • , Vinod Raina
  • , Shailesh Bondarde
  • , Minish Jain
  • , Sunhee Kwon Ro
  • , Nathalie A. Lokker
  • , Lee Schwartzberg

Research output: Contribution to journal › Article › peer-review

86   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science